The Supreme Court today unanimously struck down patents on BRCA1 and BRCA2
When Angelina Jolie announced last month that she decided to get a prophylactic double mastectomy, she based her decision on the presence of the BRCA1 gene in her body—a gene that was detected via a costly medical test.
The Supreme Court today unanimously struck down patents on BRCA1 and BRCA2—two genes linked to hereditary forms of breast and ovarian cancer—when the genes occur in the body. Myriad did not create or alter any of the genetic information of the BCRA1 and BRCA2 genes, and thus does not satisfy patenting requirements, according to the decision. “Myriad discovered the precise location and sequence of what are now known as the BRCA1 and BRCA2 genes,” Justice Clarence Thomas wrote for the court.
This ruling could lead to cheaper tests for individuals who may be at increased risk of developing cancer. If Myriad Genetics were allowed to hold exclusive patents on these genes, the company would have maintained sole rights to create medical tests that indicate whether an individual has mutations that would lead to elevated risk of developing these cancers.
The ruling should also affect the medical research community. Because the genes were patented, any researcher who found a new way to isolate the genes would not have been able to use it, since Myriad held patents on the genes themselves. The court’s decision removes that restriction.
On average, women have a 12 to 13 percent risk of developing breast cancer over their lifetimes, but that risk spikes with the presence of mutations in the BRCA1 andBRCA2 genes—jumping to between 50 and 80 percent for breast cancer and 20 and 50 percent for ovarian cancer, the decision notes.
Myriad had identified the exact location of the BRCA1 and BRCA2 genes; it had not discovered that heredity plays a role in establishing risk of breast and ovarian cancer. “Myriad did not create anything,” Thomas wrote. “To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention.” “I’m just incredibly relieved,” says Lisbeth Ceriani, a breast cancer survivor and original plaintiff who struggled to afford Myriad’s test.
The Latest Bing News on:
Gene patents
- Cell and gene manufacturers benefit from surge in FDA drug approvalson May 9, 2024 at 4:36 am
2023 marked a significant upsurge in US Food and Drug Administration (FDA) approvals, particularly for ground-breaking treatments such as cell and gene therapies.
- Emerging Legal Terrain: IP Risks from AI's Role In Drug Discoveryon May 8, 2024 at 12:52 pm
This article explores the benefits and risks of AI-driven drug discovery from the legal perspective. Since the law governing IP rights in AI-driven drug discovery is still in its infant state, any ...
- Drug patents protect pharma profits. Track when they’ll expire here.on May 8, 2024 at 10:11 am
Intellectual property is the foundation of the drug industry’s business model. This database will track key patent expiry dates for 30 top-selling medicines.
- EY Announces Gene Sheridan of Navitas Semiconductor as an Entrepreneur Of The Year® 2024 Greater Los Angeles Award Finaliston May 8, 2024 at 5:53 am
Ernst & Young LLP (EY US) today announced that Gene Sheridan, CEO and co-founder of Navitas Semiconductor (Nasdaq:NVTS) was named an Entrepreneur Of The Year ® 2024 Greater Los Angeles Award finalist.
- Editas Medicine Announces First Quarter 2024 Results and Business Updateson May 8, 2024 at 12:00 am
May 08, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company ... in the U.S. patent interference involving specific patents for CRISPR/Cas9 editing in ...
- Exclusive: Feng Zhang CRISPR startup gathers patents, locking up rights to family of editing techon May 7, 2024 at 4:00 am
In the bid to lock up patent rights to a growing suite of gene-editing technologies, Arbor Biotechnologies has acquired a small startup founded by MIT scientist and CRISPR pioneer Feng Zhang, the ...
- Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvardon May 6, 2024 at 4:59 pm
Vizgen cited as examples of anticompetitive activities what it called the unlawful bundling of 10x Genomics’ existing Chromium Single Cell Immune Profiling platform, and its Visium Spatial Gene ...
- The CRISPR Battle Through the Lens of International Patent Harmonizationon May 6, 2024 at 4:08 pm
As many readers know, CRISPR technology enables precision gene editing. The technology’s potential benefits are enormous, some of which are already being realized with the FDA’s approval of ...
- Scientists identify ‘degrees of Kevin Bacon’ geneon May 2, 2024 at 10:37 am
New research published Tuesday in the journal Nature Communications has identified a gene responsible for regulating the structure of social networks in fruit flies. The study’s authors named th ...
- Alnylam Pharmaceuticals gets grant for inhibiting expression of serum amyloid a geneon April 30, 2024 at 5:45 am
Discover the groundbreaking patent by Alnylam Pharmaceuticals Inc for a dsRNA molecule targeting Serum Amyloid A gene expression. Learn about the innovative design and potential applications in ...
The Latest Google Headlines on:
Gene patents
[google_news title=”” keyword=”gene patents” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Patent trolls
- Patent Trolls Threaten Floridian Seniors’ Access to the Interneton May 8, 2024 at 5:04 am
By Saul Anuzis Like Americans across the country, Florida’s senior citizens rely on their smartphones and laptops to access the critical broadband infrastruc ...
- Activision to pay $23.4m for patent infringementon May 7, 2024 at 8:21 am
A jury has ruled that Activision Blizzard will pay tech incubator Acceleration Bay $23.4 million for patent infringement. As reported by Law.com, the May 3 ruling comes after the incubator began its ...
- 5 Steps to Patent an Ideaon May 6, 2024 at 4:59 pm
Think you've got a million-dollar idea? You're not alone. There's always a few people out there at any moment, convinced they've got the next big app or the next popular product, while ...
- New Data Show There Is a Problem with the U.S. Patent System—But It’s Not Patent Trollson May 6, 2024 at 4:15 am
If the headlines are to be believed, every aspect of American life, from farming to football, is under threat due to excessive patent litigation. While these anecdotes may seem compelling, it is ...
- Trade secret claim still viable despite disclosure in patent applicationon May 3, 2024 at 9:02 am
May 03, 2024 - It is well established that, once a patent issues, the subject matter contained in the patent is publicly available and therefore no longer entitled to trade secret protection.
- All Galaxy smartphones affected: Samsung loses patent lawsuiton April 26, 2024 at 9:09 am
The Chinese company Datang has won in full against Samsung in the first instance. There is a threat of a sales ban, but Samsung is likely to take legal action.
- Moderna Investors Should Beware Patent-Dispute Fallouton April 23, 2024 at 11:40 am
Moderna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
- Senator introduces legislation targeting patent trollson April 23, 2024 at 3:43 am
PCWorld helps you navigate the PC ecosystem to find the products you want and the advice you need to get the job done.
- Report: Obama to announce measures against patent trollson April 23, 2024 at 3:33 am
After months on the market, Windows 8 tablets have yet to rack up the sales Microsoft and PC vendors were originally hoping for. But on Monday Taiwanese PC maker Acer showed off what could be the ...
- How two small Texas towns became the patent-law centre of Americaon April 15, 2024 at 5:00 pm
Around the same period, “it also happened that there was an explosion of patent-troll litigation,” says Paul Gugliuzza of Temple University, referring to plaintiffs who own bad patents and ...
The Latest Google Headlines on:
Patent trolls
[google_news title=”” keyword=”fix the internet” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]